Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Ogawa, Hideya"'
Publikováno v:
泌尿器科紀要. 39(8):761-764
A 55-year-old man with a 5-year history of microhematuria had a whitish sessile tumor at the ureteric ridge containing benign prostatic glandular tissue. The presence of benign prostatic polyps in the prostatic urethra is a common finding, but ectopi
Autor:
OHMORI, Hiroyuki, OHASHI, Teruhisa, KUMAMOTO, Yoshiaki, SHIRAIWA, Yasuo, SHIMAZAKI, Jun, OGAWA, Hideya, ASO, Yoshio, HISAZUMI, Haruo, KURITA, Takashi, OHKAWA, Tadashi, TANAKA, Hiroyoshi, FUJITA, Yukitoshi, SAITO, Yutaka
Publikováno v:
泌尿器科紀要. 34(12):2101-2110
尿路上皮癌526例, 前立腺癌140例を含む2, 521例に対して, プロリフィゲンTPAキット"第一"2を用いて尿中TPA濃度の測定を行った.1)健常人486例の尿中TPA濃度の平均値±標準偏差は199±218 U/lであり,
Autor:
Nakagami, Yoshizo, Lin, Tsaw Tung, Ito, Hiroshi, Hirasawa, Seiichi, Tannawa, Kunio, Fujioka, Yoshiaki, Ogawa, Hideya, Tanaka, Kyuhei, Yamada, Norimichi, Ishii, Yoji, Hikima, Norio
Publikováno v:
泌尿器科紀要. 33(10):1728-1732
The safety of prolonged administration of UFT in which tegafur and uracil were mixed in a ratio of 1:4 in molar fraction was studied in 44 cases of bladder cancer and 10 cases of renal cell carcinoma. Daily doses of UFT were 300-600 mg, and average t
Autor:
Iki, Yoshio, Ogawa, Hideya
Publikováno v:
泌尿器科紀要. 26(11):1383-1389
われわれはSSM-Vaccineを尿路・性器腫瘍に対し試験的に使用してきたが, 最近, 悪性の睾丸腫瘍による肺転移に著効がみられた症例を経験したのでその症例を報告する。なお若干の悪性膀胱
Publikováno v:
泌尿器科紀要. 14(7):485-488
A new contrast medium Conray 400 (66.8% sodium iothalamate) was used to obtain intravenous pyelogram. This medium has a character that the viscosity is low despite of high iodine content (400 mg/ml). Side effects were not significant and their degree
Publikováno v:
泌尿器科紀要. 22(6):701-703
Tolmetin sodium, a non-steroid and non-pyrine agent, was evaluated as to its anti-inflammatory and analgesic effect. In our urological use, the total effectiveness was observed in 75 % of the cases administered. Side effects were seen in 2 of 20 case
Publikováno v:
泌尿器科紀要. 15(7):536-538
1) Sensitivity test of cephalexin on 48 strains of E. coli isolated from the urinary tract infections showed the same value with kanamycin. 2) Clinical effectiveness was evaluated as 73.3% for uncomplicated urinary tract infection. 3) Daily dosage wa